FDA expanded the Pfizer booster eligibility. 12 to 15-year olds to receive booster shot.
Where: United States
The Facts
The US Food and Drug Administration (FDA) expanded the use of a single booster dose of the Pfizer-BioNTech Covid-19 vaccine to include use in individuals 12-15 years of age.
The FDA also allowed a third dose for certain immunocompromised children aged 5-11 years.
The FDA shortened the time between completion of primary vaccination and a booster dose to five months.
Chairman & CEO Pfizer, Albert Bourla, stated, “The recent rise in COVID-19 cases is concerning to all and today’s decision by the FDA to further expand the Emergency Use Authorization of a booster dose of our vaccine is critical to help us ultimately defeat this pandemic.”
Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention, is expected to rule on the boosters later this week.
Primary Sources
Direct, authoritative source material on this story.
Reference Articles
Articles Citable has ingested related to this story.
Reference Articles
Articles Citable has ingested related to this story.
Media Coverage
Why did we include this story
Most covered story by the media today
of articles referenced this story
Coverage by Media Outlet
Media outlets covering this story along with their positive or negative sentiment toward this story.
